Subject: Biotech and Medical Sciences

Why in the News?

The financial strain of cancer is often ignored but can be the most harmful. It not only impacts the patient but also their family and future generations.

What is the extent of financial toxicity faced by cancer patients in India?

• High Treatment Costs: Cancer treatments, especially advanced options like immunotherapy, can be prohibitively expensive. For instance, a patient with oral cancer may face annual costs of approximately ₹10 lakh, adding to previous expenses that can total ₹25 lakh over several years. This financial strain often forces families to deplete savings or sell assets to afford care.
• Impact on Families: Financial toxicity extends beyond the patient to their families, leading to severe economic consequences. Families may resort to selling properties or skipping meals to manage treatment costs, which can entrap them in a cycle of generational poverty.
• Out-of-Pocket Expenses: A significant portion of healthcare costs is borne out-of-pocket by patients. For example, outpatient expenses can account for nearly 50% of total healthcare costs, which are not covered by insurance schemes like Ayushman Bharat.

What are the contributing factors to financial toxicity in cancer care?

• Inadequate Public Health Funding: India’s public health expenditure has historically been below 2% of GDP, resulting in insufficient healthcare infrastructure and personnel in public hospitals. This leads to delays in diagnosis and treatment, particularly for advanced cancer cases that require more costly interventions.
• Limited Insurance Coverage: Existing insurance schemes primarily cover inpatient costs, leaving patients responsible for outpatient diagnostics and follow-up treatments. This gap significantly contributes to the financial burden on patients and their families.
• Economic Disparities: Patients from low and middle-income backgrounds face additional hurdles in accessing cutting-edge treatments due to their high costs and limited availability in public health systems.

What strategies can be implemented to mitigate financial toxicity? (Way forward)

• Strengthening Public Healthcare: Increasing government investment in public health could improve access to affordable cancer care.
  • States like Delhi and Kerala have initiated schemes to support direct medical costs, but broader implementation is needed across India.
• Supportive Measures for Non-Medical Costs: Initiatives such as discounted travel fares for cancer patients can alleviate some financial burdens associated with non-medical expenses. Expanding these programs could provide significant relief.
• Role of Nonprofits and CSR: Nonprofit organizations play a crucial role in reducing out-of-pocket expenses through various support services. Increased funding from corporate social responsibility (CSR) initiatives could help these organisations expand their reach and impact.
• Promoting Philanthropy: Encouraging individual philanthropy among wealthier segments of society could provide critical funding for cancer care initiatives and nonprofits focused on assisting low-income patients.
• Policy Advocacy: Advocating for policies that address the gaps in insurance coverage and promote equitable access to cancer treatments is essential for reducing financial toxicity in the long term.

Mains PYQ:

Q What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of the society? (UPSC IAS/2021)

Mentor’s Comment: UPSC Mains has always focused on traditional knowledge of medicine (2019) and the health sector (2020).

A recent Supreme Court ruling in the case of Bhagwati Medical Hall vs Central Drugs Standard Control Organization & Ors. has highlighted the difficult challenge faced by state governments in controlling the public health risk caused by alcoholic tinctures sold as homoeopathic remedies in India. Despite the Union Government’s efforts to address the issue, the strong influence of the homoeopathic industry has often led to legal battles that prevent real progress.

Today’s editorial discusses the difficult challenge state governments face in managing the health risks from alcoholic tinctures sold as homoeopathic medicines in India. This information can be useful for supporting your argument in GS Paper 1 and 2 answers.

_

Let’s learn!

Why in the News?

Alcoholic tinctures sold as homoeopathic remedies in India pose a serious risk to public health.

What are the implications of the recent regulatory changes in homoeopathy?

• Regulatory Complexity and Taxation Issues: The regulatory architecture for homoeopathic alcoholic tinctures is highly complex, with overlapping jurisdictions between the Union and States.
  • Post-GST, alcohol for medicinal purposes is taxed at 18%, significantly lower than State taxes on alcoholic beverages, making homoeopathic tinctures a cheaper alternative for consumers.
  • States cannot regulate these tinctures without presidential assent, leading to a lack of quality control and public health oversight.
• Public Health Hazards: Homoeopathic tinctures containing 12% alcohol are often consumed as substitutes for alcoholic beverages, leading to alcohol-related illnesses such as alcoholic hepatitis.
  • For example: States like Gujarat and Bihar, where alcohol is prohibited, have reported deaths due to the consumption of spurious homoeopathic tinctures..
• Industry Lawfare and Regulatory Delays: The homoeopathic industry has consistently challenged regulations, such as Rule 106B of the Drugs and Cosmetics Rules, 1945, through prolonged litigation.
  • The Union government’s decision to pursue litigation instead of laying Rule 106B before Parliament has further delayed regulatory enforcement.

How does the public perception of homoeopathy impact healthcare choices?

• Misleading Perception of Safety: Many consumers perceive homoeopathic remedies as safe and natural, unaware of the high alcohol content in tinctures.
  • This perception leads to the misuse of homoeopathic tinctures as substitutes for alcoholic beverages, especially in prohibition States like Bihar and Gujarat.
• Lack of Awareness: Poorly informed consumers may consume homoeopathic tinctures daily, believing they are curing ailments, while unknowingly risking alcohol-related diseases.
  • The absence of clear labelling and warnings exacerbates the problem, as consumers are not fully aware of the health risks associated with these products.
• Impact on Healthcare Choices: The availability of cheap, alcohol-based homoeopathic tinctures influences healthcare choices, particularly among low-income groups seeking affordable alternatives to conventional medicine.
  • This reliance on homoeopathy can delay or prevent access to evidence-based medical treatments, worsening health outcomes.

What role should evidence-based research play in validating homoeopathic practices? (Way forward)

• Need for Regulatory Reforms: Research should inform regulatory decisions, such as whether alcohol should be permitted in homoeopathic and ayurvedic products.
  • Countries like the U.S. and U.K. are considering cancer warnings on alcoholic beverages, highlighting the need for similar scrutiny of alcohol-based medicinal products in India.
• Public Health Policy: Evidence-based research can guide public health policies, ensuring that regulations prioritize consumer safety over industry interests.
  • Research should also address the misuse of homoeopathic tinctures as substitutes for alcoholic beverages, particularly in prohibition States.